VKTX
Viking Therapeutics, Inc
stockNASDAQ
Market OpenNov 10, 2026 1:44:50 PM EST
28.86USD-0.431%(-0.13)2,350,683
Pre-marketNov 10, 2026 9:27:30 AM EST
28.80USD-0.655%(-0.19)
VKTX Financials
In Q3 FY 2026 (ended ), Viking Therapeutics, Inc (VKTX) reported revenue of $0, net income of −$183.19M, operating cash flow of −$138.19M, and assets of $977.17M (filed ).
Loading financial statements…